Overview

A Study of XW003 Injection in Chinese Adolescents With Obesity

Status:
RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XW003 injection in Chinese adolescents with obesity
Phase:
PHASE1
Details
Lead Sponsor:
Hangzhou Sciwind Biosciences Co., Ltd.